Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Jobs News Tylenol Maker Kenvue To Cut 4 Jobs, Beats Quarterly Profit Estimates is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates
Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter profit. Read More
Neutrogena-Maker Kenvue Beats Profit Forecast, Ups Sales Outlook (UPDATED) - Yahoo Finance
Editor’s Note: Self care segment revenue growth updated Consumer health company Kenvue Inc. (NYSE:KVUE) on Thursday reported first-quarter 2025 sales of $3.74 billion, beating the consensus of ... Read More
Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Net Sales Outlook
Shares of Kenvue (KVUE) rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates. The former consumer ... Read More
Listerine-Maker Kenvue Beats Estimates on Strong Essential Health Product Sales - U.S. News
(Reuters) -Kenvue beat Wall Street estimates for second-quarter profit and revenue on Tuesday, helped primarily by better-than-expected sales in its essential health products unit that sells ... Read More
Can Maker Ball Corp Beats Quarterly Profit Estimates on Lower Costs - U.S. News
Reuters. FILE PHOTO: Aluminium cans leave the production line at Ball Corporation, Wakefield, Britain, October 18, 2019. REUTERS/Andrew Yates/File photo ... Read More
Band-Aid, Tylenol Parent Kenvue Reports Healthy Full-Year Guidance - Investopedia
Q2 Revenue Beats Estimates, EPS Misses In the second quarter, the company posted earnings per share (EPS ) of 3 cents on revenue of $4 billion. Analysts had called for EPS of 24 cents on revenue ... Read More
Neutrogena-Maker Kenvue Beats Profit Forecast, Ups Sales Outlook - Benzinga
Kenvue beat Q1 sales estimates and updated its 2025 forecast as it ... Neutrogena-Maker Kenvue Beats Profit Forecast, Ups ... Neutrogena, and Tylenol. Gross profit margin was 58.0% vs. 57 ... Read More
Listerine-maker Kenvue beats estimates on strong essential health product sales | Reuters
Kenvue beat Wall Street estimates for second-quarter profit and revenue on Tuesday, helped primarily by better-than-expected sales in its essential health products unit that sells brands including ... Read More
Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Net Sales Outlook - Investopedia
Shares of Kenvue rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates. Skip to content News ... Read More
Listerine-maker Kenvue beats estimates on strong essential health product sales - AOL
On an adjusted basis, Kenvue posted a profit of 32 cents per share, beating analysts' estimates by 4 cents. The company maintained its adjusted profit forecast for the year at between $1.10 and $1 ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus